INTRODUCTION
The ACE (Adverse Childhood Experiences) concept is based on the results of an American population-based cohort study published in the American Journal of Preventive Medicine in 1998. ACE is classified into three groups: abuse...
BACKGROUND
Alcohol abuse and addiction are a widespread problem that leads to a serious collision and pose a serious threat to individuals as well as to society as a whole. In addition to the health aspect of alcohol consumption, social...
BACKGROUND: The identity and social representation of people linked to drugs depend on their interaction with the system that collects and analyses the critical data used to describe it. AIM: The aim of this study is to see if by adopting a...
Chaired by Livia Edegger, Deputy Director of the International Society of Substance Use Professionals (ISSUP), the specialist in this panel spoke about the importance of creating and strengthening the workface in drug demand reduction...
New Zealand is making history with the launch of a bold Smokefree Action Plan that aims to reduce daily smoking prevalence to less than 5 percent for all population groups across the country by 2025.
The aim of the new plan is to...
What do we mean by evidence and why does it matter?
This article, published by Drugs Research Network Scotland, discusses the hierarchy of evidence and the way evidence can be used to inform effective and efficient drug policy and practice...
Here you can read the UK governments 10-year plan to reduce illegal drug use.
The 10-year plan is also the formal, substantive response to the Independent Reviews of Drugs led by Dame Carol Black and accepts all of her key recommendations...
There is a scarcity of research on drug use patterns among HIV-positive young individuals in Sub-Saharan Africa (YLWH). To fill the gap, the following was set out:
Evaluation is an integral part of a good governance approach to public policy. This principle applies equally to the component of drug policy designed to counter the availability of and access to illicit drugs. Estimation or full costing of...
